US Broker Ratings

Dianthus Therapeutics, Inc. (DNTH): Investor Outlook on a Promising Biotech with a 41% Potential Upside

Dianthus Therapeutics, Inc. (NASDAQ: DNTH) is catching the eyes of investors with a staggering 41.01% potential upside, according to the latest analyst ratings. This clinical-stage biotechnology company is making strides..

Valneva SE (VALN) Stock Analysis: Navigating the Healthcare Sector with a 30% Potential Upside

Valneva SE (VALN), a French biotech firm specializing in the development and commercialization of vaccines for unmet medical needs, presents a compelling narrative for investors keen on the healthcare sector...

Spyre Therapeutics, Inc. (SYRE): Unlocking 59% Potential Upside in Biotechnology

Spyre Therapeutics, Inc. (SYRE) stands out as a promising player in the biotechnology sector, particularly for investors eyeing significant growth prospects. As a clinical-stage biotech company, Spyre is focused on..

CorMedix Inc. (CRMD) Stock Analysis: A Biotech Gem with a 78.57% Potential Upside

Investors with a keen eye on the biotechnology sector may find CorMedix Inc. (NASDAQ: CRMD) a compelling opportunity. With a significant potential upside of 78.57%, as indicated by its average..

Niagen Bioscience, Inc. (NAGE) Stock Analysis: A Potential 135% Upside Awaits Investors

Niagen Bioscience, Inc. (NAGE), a U.S.-based biotechnology company specializing in healthy aging products, is garnering significant attention with a market capitalization of $534.7 million. Amidst the ever-evolving healthcare sector, Niagen..

Embecta Corp. (EMBC): Investor Outlook with a 42.69% Potential Upside in the Healthcare Sector

Embecta Corp. (NASDAQ: EMBC), a stalwart in the healthcare sector, is drawing attention from investors with its significant potential upside. Specializing in medical instruments and supplies, particularly for diabetes care,..

uniQure N.V. (QURE) Stock Analysis: Uncovering a Potential 158.78% Upside in the Biotech Sector

In the dynamic landscape of biotechnology, uniQure N.V. (NASDAQ: QURE), a Netherlands-based company, is capturing investor attention with a striking potential upside of 158.78%, according to analyst consensus. This biotech..

Butterfly Network, Inc. (BFLY) Stock Analysis: Uncovering a 28% Upside Potential in the Medical Devices Industry

Butterfly Network, Inc. (BFLY), a pioneering company in the medical devices sector, has captured the attention of investors with its innovative approach to ultrasound imaging solutions. As a leading player..

Simulations Plus, Inc. (SLP): Investor Outlook Reveals 9% Potential Upside Amidst Unique Software Offerings

Investors with an eye on innovation in the healthcare technology sector might find Simulations Plus, Inc. (SLP) an intriguing prospect. The company, a staple in the Health Information Services industry,..

InMode Ltd. (INMD) Stock Analysis: Navigating the Healthcare Industry with a 17.15% Potential Upside

Investors eyeing the healthcare sector should consider InMode Ltd. (NASDAQ: INMD), a promising player in the medical devices industry with a notable potential upside of 17.15%. Based in Israel, InMode..

SI-BONE, Inc. (SIBN) Stock Analysis: Unveiling a 31% Potential Upside in the Medical Devices Sector

SI-BONE, Inc. (SIBN) is gaining attention in the healthcare sector, particularly within the medical devices industry, as it showcases a compelling growth narrative. Headquartered in Santa Clara, California, SI-BONE focuses..

Taysha Gene Therapies (TSHA) Stock Analysis: Promising Upside of 108.92% Amidst Biotech Innovation

Taysha Gene Therapies, Inc. (NASDAQ: TSHA) has captured investor attention with a formidable potential upside of 108.92%, according to analyst ratings. This impressive figure is set against the backdrop of..

Kura Oncology (KURA) Stock Analysis: A Biotech with 175% Potential Upside

Kura Oncology, Inc. (NASDAQ: KURA), a clinical-stage biopharmaceutical company, is capturing investor attention with its robust pipeline focused on developing innovative cancer treatments. Headquartered in San Diego, California, Kura Oncology..

Akebia Therapeutics, Inc. (AKBA) Stock Analysis: Exploring a 239.62% Potential Upside

Akebia Therapeutics, Inc. (AKBA), a dynamic player in the healthcare sector, has garnered significant attention, particularly in the specialty and generic drug manufacturing industry. With its focus on developing therapeutics..

HealthStream, Inc. (HSTM) Stock Report: Potential Upside of 37.60% Amid Steady Growth

HealthStream, Inc. (NASDAQ: HSTM) is capturing investor attention with its robust position in the healthcare technology sector, offering a suite of Software-as-a-Service (SaaS) applications designed to streamline operations within healthcare..

Stoke Therapeutics, Inc. (STOK): Investor Outlook with Promising Revenue Growth and Strong Analyst Support

Stoke Therapeutics, Inc. (NASDAQ: STOK) has emerged as a captivating prospect in the biotechnology sector, showcasing remarkable revenue growth and robust analyst support. With a market capitalization of $1.77 billion,..

Xeris Biopharma Holdings (XERS) Stock Analysis: A Biotech Growth Prospect with 71% Upside Potential

For investors eyeing potential opportunities in the healthcare sector, Xeris Biopharma Holdings, Inc. (NASDAQ: XERS) presents a compelling case. As a biopharmaceutical company, Xeris is making significant strides in treating..

Cronos Group Inc. (CRON) Stock Analysis: Navigating the Cannabis Market with a 6.10% Revenue Growth

Cronos Group Inc. (CRON), a key player in the cannabis industry, continues to make its mark from its base in Stayner, Canada. Specializing in the cultivation and marketing of cannabis..

Akso Health Group (AHG): Investor Outlook on a High-Growth Healthcare Disruptor

Akso Health Group (AHG), a dynamic player in China’s healthcare sector, is capturing the attention of investors with its impressive revenue growth. Operating primarily through its social e-commerce platform, Xiaobai..

Community Health Systems, Inc. (CYH) Stock Analysis: Evaluating a 7.63% Potential Upside in the Healthcare Sector

Community Health Systems, Inc. (NYSE: CYH) stands at an intriguing intersection within the healthcare sector, specifically in the medical care facilities industry. With a market cap of $508.63 million, the..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds